Can Alternative Treatment Have an Impact on Cervical Dysplasia?
Overview
In this study two questions will be answered: – can mindfulness meditation help cell-changed on the cervix to disappear? – can mindfulness meditation lower the psychological distress when women have abnormal cervical cancer screening results?
Full Title of Study: “Can Mindfulness Meditation Limit the Progression and/or Increase the Remission of Cervical Dysplasia?”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Primary Purpose: Treatment
- Masking: None (Open Label)
- Study Primary Completion Date: June 2010
Detailed Description
200 women, who have participated in cervical cancer screening and have mild dysplasia, will be randomized into two groups; an intervention group and a control group. The intervention group will be asked to do mindfulness meditation twice a week listening to instructions from a CD. 200 additional women having normal cervical screening results will also be included in the project.
Interventions
- Behavioral: Mindfulness meditation
- Mindfulness meditation
- Other: No meditation
- Health care services as usual
- Other: Controls
- No intervention
Arms, Groups and Cohorts
- Active Comparator: Mindfulness meditation
- Women with mild dysplasia offered mindfulness meditation
- Other: No meditation
- Women with mild dysplasia offered health care services as usual
- Other: Controls
- Women with normal cervical cells
Clinical Trial Outcome Measures
Primary Measures
- The degree of cervical dysplasia
- Time Frame: 6 months after screening
Secondary Measures
- Psychosocial consequences measured with the COS-CC questionnaire
- Time Frame: 1 week, 3 and 9 months after screening
Participating in This Clinical Trial
Inclusion Criteria
- Women aged 23-29 years – Participated in cervical cancer screening – Having mild dysplasia and normal screening results Exclusion Criteria:
- Women who have previously had dysplasia
Gender Eligibility: Female
Minimum Age: 23 Years
Maximum Age: 29 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- University of Copenhagen
- Collaborator
- Danish Cancer Society
- Provider of Information About this Clinical Study
- John Brodersen, MD, GP, PhD, Associate Professor, Department and Research Unit of G.P., Institute of Public Health, Uni of Copenhagen
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.